Understanding New Options for CLL: Session 1 Replay

Published on

Topics include: Treatments

Watch the replay of session one of our “Understanding New Options for CLL” town meeting, as leading experts, Dr. Michael Keating and Dr. Nicole Lamanna, discuss the latest CLL research. Learn more about current therapies, approaches on the horizon, and how to work with your healthcare team to find the best treatment for you. 

Provided by CLL Global Research Foundation, which received support from AbbVie Inc., Genentech Inc., Gilead Sciences, Pharmacyclics, Inc., Teva Pharmaceuticals and TG Therapeutics. In partnership with The University of Texas MD Anderson Cancer Center.

View more programs featuring , , , and

Produced in association with and

Related Programs

Dr. Michael Keating: My Perspective on CLL Research News

What CLL research advances are in the pipeline, and will they be available to everyone soon? Dr. Michael Keating explains.


Exploring Second-Generation CLL Inhibitors

Why should patients be interested in second-generation CLL inhibitors? Drs. Lamanna and Thompson explain.


Checkpoint Inhibitors and CLL

Could checkpoint inhibitors be used to treat CLL? CLL expert, Dr. Nicole Lamanna, explains.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on May 24, 2019